
Training Tuesday!
Join us in celebrating our new CaRE2 graduate student, Kyle Phillips. 🧪🔬👩🏽🔬 #CancerResearch #CaRE2 #CaRE2HEC #TrainingTuesday
Join us in celebrating our new CaRE2 graduate student, Kyle Phillips. 🧪🔬👩🏽🔬 #CancerResearch #CaRE2 #CaRE2HEC #TrainingTuesday
Join CaRE2 at the Colorectal Cancer Awareness Community Health Fair, on March 29th, 2025, 10 AM- 2 PM EST at 100 N. Dean Rd, Orlando
Happy Cancer Myths and Misconceptions Monday! Feliz Lunes de Mitos y Malentendidos sobre el cáncer! #CaRE2 #debunkingcancermyths #CancerResearch #InvestigaciondelCáncer #HealthEquity #CaRE2HEC #MultipleMyelomaMonth
Today we celebrate the power, resilience, and achievements of women around the world. Let’s continue to uplift, empower, and support one another in every space
Join CaRE2 on Saturday March, 29, 10 AM – 2PM PST at West Edge Plaza, Santa Monica for the Colorectal Cancer Awareness Celebration! Enjoy music,
Multiple myeloma is the second most common blood cancer, affecting plasma cells in the bone marrow. Stay informed, support research, and spread awareness! #CancerResearch #EarlyDetectionSavesLives
Celebrate Women’s History Month by taking action! Schedule your cancer screening, raise awareness, and advocate for better healthcare for all women. Early detection saves lives!
Join our RadTox Focus Groups! Are you a cancer patient or caregiver living in Florida? We are looking for participants 18+ to share their feedback
Join our FREE Prostate Cancer Advocate Training on Thursday, March 20th, 2025, from 6:00 PM – 8:00 PM EST | 3:00 PM – 5:00 PM
#CaRE2 #debunkingcancermyths #CancerResearch #InvestigaciondelCáncer #HealthEquity #CaRE2HEC #ColorectalCancerMonth
Colorectal cancer is the second leading cause of cancer-related deaths in the U.S. but its preventable and highly treatable when detected early. Regular screenings save
Kidney cancer is one of the top 10 most common cancers in both men and women. Early detection can save lives, so it’s important to
Stay up to date with the latest news and information about CaRE2